UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

Journal of clinical oncology, 2009-02, Vol.27 (4), p.511-518

2009

Link zum Volltext

Verfügbarkeit prüfen

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4656-4663

2009

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3 -Internal Tandem Duplication Mutation (SORMAIN)

Journal of clinical oncology, 2020-09, Vol.38 (26), p.2993-3002

2020

Link zum Volltext

Verfügbarkeit prüfen

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival

Neuroendocrinology, 2017-01, Vol.104 (1), p.26-32

2017

Link zum Volltext

Verfügbarkeit prüfen

The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)

Leukemia, 2021-10, Vol.35 (10), p.2917-2923

2021

Link zum Volltext

Verfügbarkeit prüfen

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial

Lancet neurology, 2018-03, Vol.17 (3), p.223-231

2018

Link zum Volltext

Verfügbarkeit prüfen

Short-term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo-controlled trial

Movement disorders, 2008-05, Vol.23 (7), p.942-949

2008

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of a Low-threshold, Culturally-Sensitive Group Psychoeducation Programme for Asylum Seekers (LoPe): study protocol for a multicentre randomised controlled trial

BMJ open, 2021-10, Vol.11 (10), p.e047385-e047385

2021

Link zum Volltext

Verfügbarkeit prüfen

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease

Neurology, 2019-03, Vol.92 (10), p.e1109

2019

Link zum Volltext

Verfügbarkeit prüfen

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

The lancet respiratory medicine, 2021-05, Vol.9 (5), p.476-486

2021

Link zum Volltext

Verfügbarkeit prüfen

Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)

International journal of gynecological cancer, 2021-07, Vol.31 (7), p.1075-1079

2021

Link zum Volltext

Verfügbarkeit prüfen

Culturally adapted cognitive behavioural group therapy for mental disorders in refugees plus problem solving training (ReTreat): study protocol for a multicentre randomised controlled trial

BMJ open, 2022-11, Vol.12 (11), p.e061274-e061274

2022

Link zum Volltext

Verfügbarkeit prüfen

Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)

Leukemia, 2021-10, Vol.35 (10), p.3038-3038

2021

Link zum Volltext

Verfügbarkeit prüfen

MIRACUM: Medical Informatics in Research and Care in University Medicine

Methods of information in medicine, 2018-07, Vol.57 (S 01), p.e82

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group

Blood, 2022-11, Vol.140 (Supplement 1), p.1501-1503

2022

Link zum Volltext

Verfügbarkeit prüfen

Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial

Parkinsonism & related disorders, 2019-08, Vol.65, p.217-223

2019

Link zum Volltext

Verfügbarkeit prüfen

Superficial Surgical Site Infection Following the Use of Intracutaneous Sutures Versus Staples

Deutsches Ärzteblatt international, 2019-05, Vol.116 (21), p.365-371

2019

Link zum Volltext

Verfügbarkeit prüfen

Superficial Surgical Site Infection Following the Use of Intracutaneous Sutures Versus Staples: A Randomized Single-Center Trial in an Elective Gastrointestinal Surgery Setting

Deutsches Ärzteblatt international, 2019-05, Vol.116 (21), p.365-371

2019

Link zum Volltext

Verfügbarkeit prüfen

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas : A phase II multicenter study

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3257-3263

1998

Link zum Volltext

Verfügbarkeit prüfen

Placebo controlled, double blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors (PROMID): Results on long-term survival

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.4030-4030

2013

Link zum Volltext

Verfügbarkeit prüfen

Radioimmunotherapy of small-volume disease of metastatic colorectal cancer: Results of a Phase II trial with the iodine-131-labeled humanized anti-carcinoembryonic antigen antibody hMN-14

Cancer, 2002-02, Vol.94 (4), p.1373-1381

2002

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation

Annals of hematology, 2011-03, Vol.90 (3), p.301-306

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(24)
Female
(20)
Male
(18)
Adult
(15)
Middle Aged
(14)
Oncology
(14)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Double-Blind Method
(9)
Treatment Outcome
(9)
Aged
(7)
Hematology
(7)
Adolescent
(5)
Follow-Up Studies
(5)
Neurosciences & Neurology
(5)
Quality Of Life
(5)
Radioimmunotherapy
(5)
Antineoplastic Agents - Adverse Effects
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incorporation of pazopanib in maintenance therapy of ovarian cancer

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3 -Internal Tandem Duplication Mutation (SORMAIN)

Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [11C] (R)-PK11195 PET (MEMSA-trial)

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival

The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial

Short-term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo-controlled trial

Efficacy of a Low-threshold, Culturally-Sensitive Group Psychoeducation Programme for Asylum Seekers (LoPe): study protocol for a multicentre randomised controlled trial

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)

Culturally adapted cognitive behavioural group therapy for mental disorders in refugees plus problem solving training (ReTreat): study protocol for a multicentre randomised controlled trial

Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)

MIRACUM: Medical Informatics in Research and Care in University Medicine

Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group

Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial

Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial

Superficial Surgical Site Infection Following the Use of Intracutaneous Sutures Versus Staples

Superficial Surgical Site Infection Following the Use of Intracutaneous Sutures Versus Staples: A Randomized Single-Center Trial in an Elective Gastrointestinal Surgery Setting

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas : A phase II multicenter study

Placebo controlled, double blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors (PROMID): Results on long-term survival

Radioimmunotherapy of small-volume disease of metastatic colorectal cancer: Results of a Phase II trial with the iodine-131-labeled humanized anti-carcinoembryonic antigen antibody hMN-14

Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation

Suchergebnisse filtern